Concepedia

Michel Afargan

MA

6

Publications

330

Citations

6

H-Index

1998

Active since

Affiliations

Hebrew University of Jerusalem(Current)

Michel Afargan is an author at Hebrew University of Jerusalem specializing in medicine, pharmacology, and diabetes.

Top concepts

Publications per year

1998–2006

6

Publications

6

Novel Long-Acting Somatostatin Analog with Endocrine Selectivity: Potent Suppression of Growth Hormone But Not of Insulin

Michel Afargan, Eva Tiensuu Janson, Garry Gelerman et al. · Endocrinology · 2001 · 83 citations · Full text

Gastroretentive Accordion Pill: Enhancement of riboflavin bioavailability in humans

Leonid Kagan, Noa Lapidot, Michel Afargan et al. · Journal of Controlled Release · 2006 · 77 citations

, , +4

A Backbone-Cyclic, Receptor 5-Selective Somatostatin Analogue:  Synthesis, Bioactivity, and Nuclear Magnetic Resonance Conformational Analysis

Chaim Gilon, Martin Huenges, Barbara Mathä et al. · Journal of Medicinal Chemistry · 1998 · 59 citations

Human Somatostatin Receptor Specificity of Backbone-Cyclic Analogues Containing Novel Sulfur Building Units

Sharon Gazal, Garry Gelerman, Ofer Ziv et al. · Journal of Medicinal Chemistry · 2002 · 46 citations · Full text

A novel somatostatin analogue prevents early renal complications in the nonobese diabetic mouse

Daniel Landau, Yael Segev, Michel Afargan et al. · Kidney International · 2001 · 36 citations · Full text

, , +12

Rows per page

1–5 of 6